GlassScriptPhysician profile
Thomas P Joseph
NPI 1861430092
$8,123.92
in general payments reported to CMS, 2019-2025
38 companies · $43.16 in 2025
The $43.16 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,995 · 2020: $281 · 2021: $710 · 2022: $728 · 2023: $608 · 2024: $759 · 2025: $43.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,284 · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,283.91 |
| Education | $126.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,254.43 | 2019-2025 | Calquence |
| Genzyme Corporation | $503.64 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $391.36 | 2019-2020 | |
| Amgen INC. | $342.64 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $329.02 | 2019-2022 | |
| Abbott Laboratories | $264.96 | 2023-2024 | Coroflow, Optis |
| Glaxosmithkline, LLC. | $257.97 | 2019-2022 | |
| Beigene USA, INC. | $220.41 | 2022-2023 | Brukinsa |
| Medtronic USA, INC. | $182.54 | 2019 | |
| Eisai INC. | $169.34 | 2019-2023 | |
| Pfizer INC. | $161.29 | 2019-2022 | |
| Gilead Sciences, INC. | $152.86 | 2019-2023 | Trodelvy |
| Kite Pharma, INC. | $150.00 | 2024 | Yescarta |
| Sanofi-Aventis U.S. LLC | $138.88 | 2021 | |
| Blueprint Medicines Corporation | $129.21 | 2024 | Ayvakit |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $123.95 | 2019 | |
| Genentech USA, INC. | $123.40 | 2019 | |
| Tempus Ai, INC | $115.61 | 2024 | |
| Ethicon US, LLC | $114.74 | 2022 | |
| Seagen INC. | $112.67 | 2019-2023 | Adcetris |
| Lilly USA, LLC | $110.79 | 2019 | |
| Myriad Genetic Laboratories, INC. | $106.68 | 2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Intuitive Surgical, INC. | $95.85 | 2024 | |
| Pinnacle Biologics, INC | $77.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $73.62 | 2019-2020 | |
| Janssen Biotech, INC. | $67.40 | 2019-2020 | |
| Puma Biotechnology, INC. | $40.79 | 2019 | |
| Clovis Oncology, INC. | $39.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.00 | 2019 | |
| Tesaro, INC. | $24.64 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $21.96 | 2019 | |
| Erbe USA INC | $20.00 | 2024 | |
| Alexion Pharmaceuticals, INC. | $19.76 | 2019 | |
| Btg International INC. | $17.29 | 2019 | |
| Karyopharm Therapeutics INC. | $16.89 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.29 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.